Skip to content

JUMATEX: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

JUMATEX

BE 0426.188.207
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€58,759
2024 · -€29,281-€29,478
Equity
-€477,732
2024 · -€418,973-€58,759
Cash
€39,911
2024 · €34,453+€5,458
Balance sheet total
€369,879
2024 · €393,178-€23,299

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€19,109

    down €19,109 (-18.6%), from €102,638 to €83,528

    of which Land and buildings: -€12,786

  • Stocks and contracts -€5,806

    down €5,806 (-5.8%), from €99,995 to €94,189

  • Cash +€5,458

    up €5,458 (+15.8%), from €34,453 to €39,911

    mainly Other debts (+€67,775) and Depreciation (+€20,065)

  • Deferred charges and accrued income -€4,618

    down €4,618 (-86.1%), from €5,365 to €747

Equity and liabilities
  • Other debts +€67,775

    up €67,775 (+10.5%), from €646,729 to €714,505

  • Profit (loss) carried forward -€58,759

    down €58,759 (-11.8%), from -€499,874 to -€558,633

  • Current portion of long-term debt -€25,000

    down €25,000 (-100%), from €25,000 to €0

  • Tax, wage and social debts -€17,307

    down €17,307 (-41.2%), from €42,022 to €24,715

    of which Remuneration and social security: -€13,644

  • Trade debts +€5,163

    up €5,163 (+5.4%), from €95,618 to €100,782

Income statement
  • Gross operating margin -€51,787

    down €51,787 (-20.5%), from €252,181 to €200,394

  • Depreciation -€37,105

    down €37,105 (-64.9%), from €57,170 to €20,065

  • Other operating charges +€9,141

    up €9,141 (+88.8%), from €10,290 to €19,431

  • Staff costs +€5,674

    up €5,674 (+2.7%), from €209,259 to €214,933

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€29,281
Gross operating margin -€51,787
Staff costs -€5,674
Depreciation +€37,105
Other operating charges -€9,141
Financial income -€243
Financial charges +€262
Result 2025 -€58,759
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€31,414
Investment -€956
Financing -€25,000
Cash 2024 €34,453
Net result for the year -€58,759
Depreciation +€20,065
Stocks and contracts +€5,806
Receivables within one year -€776
Deferred charges and accrued income +€4,618
Trade debts +€5,163
Tax, wage and social debts -€17,307
Other debts +€67,775
Accrued charges and deferred income +€4,829
Investment in fixed assets (net) -€956
Current portion of long-term debt -€25,000
Cash 2025 €39,911
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €393,178 €369,879 -€23,299 -5.9%
Fixed assets 21/28 €104,663 €85,554 -€19,109 -18.3%
Tangible fixed assets 22/27 €102,638 €83,528 -€19,109 -18.6%
Land and buildings 22 €82,001 €69,215 -€12,786 -15.6%
Plant, machinery and equipment 23 €19,122 €13,771 -€5,351 -28.0%
Furniture and vehicles 24 €1,514 €542 -€973 -64.2%
Financial fixed assets 28 €2,025 €2,025 = 0.0%
Current assets 29/58 €288,514 €284,325 -€4,190 -1.5%
Stocks and contracts in progress 3 €99,995 €94,189 -€5,806 -5.8%
Stocks 30/36 €99,995 €94,189 -€5,806 -5.8%
Amounts receivable within one year 40/41 €118,625 €119,401 +€776 +0.7%
Trade receivables 40 €44,639 €44,553 -€86 -0.2%
Other amounts receivable 41 €73,986 €74,848 +€862 +1.2%
Current investments 50/53 €30,076 €30,076 = 0.0%
Cash at bank and in hand 54/58 €34,453 €39,911 +€5,458 +15.8%
Deferred charges and accrued income 490/1 €5,365 €747 -€4,618 -86.1%
Total equity and liabilities 10/49 €393,178 €369,879 -€23,299 -5.9%
Equity 10/15 -€418,973 -€477,732 -€58,759 -14.0%
Contributions 10/11 €33,466 €33,466 = 0.0%
Revaluation surpluses 12 €5,070 €5,070 = 0.0%
Reserves 13 €42,365 €42,365 = 0.0%
Distributable reserves 133 €42,365 €42,365 = 0.0%
Profit (loss) carried forward 14 -€499,874 -€558,633 -€58,759 -11.8%
Amounts payable 17/49 €812,151 €847,611 +€35,460 +4.4%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €809,370 €840,001 +€30,631 +3.8%
Current portion of amounts payable after more than one year 42 €25,000 €0 -€25,000 -100%
Trade debts 44 €95,618 €100,782 +€5,163 +5.4%
Suppliers 440/4 €95,618 €100,782 +€5,163 +5.4%
Taxes, remuneration and social security 45 €42,022 €24,715 -€17,307 -41.2%
Taxes 450/3 €3,663 €0 -€3,663 -100%
Remuneration and social security 454/9 €38,359 €24,715 -€13,644 -35.6%
Other amounts payable 47/48 €646,729 €714,505 +€67,775 +10.5%
Accrued charges and deferred income 492/3 €2,781 €7,610 +€4,829 +174%
Remuneration, social security and pensions 62 €209,259 €214,933 +€5,674 +2.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €57,170 €20,065 -€37,105 -64.9%
Other operating charges 640/8 €10,290 €19,431 +€9,141 +88.8%
Gross operating margin 9900 €252,181 €200,394 -€51,787 -20.5%
Operating profit (loss) 9901 -€24,538 -€54,035 -€29,497 -120%
Financial income 75/76B €510 €267 -€243 -47.6%
Recurring financial income 75 €510 €267 -€243 -47.6%
Financial charges 65/66B €5,253 €4,991 -€262 -5.0%
Recurring financial charges 65 €5,253 €4,991 -€262 -5.0%
Profit (loss) for the period before taxes 9903 -€29,281 -€58,759 -€29,478 -101%
Profit (loss) for the period 9904 -€29,281 -€58,759 -€29,478 -101%
Profit (loss) for the period to be appropriated 9905 -€29,281 -€58,759 -€29,478 -101%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.